Could Prevention Data Give REGEN-COV Competitive Leg Up?

 
• By Alaric DeArment
  
Antibodies immunoglobulins attacking coronavirus covid-19 influenza virus cell, 3D immune system medical illustration background. Corona virus 2019-ncov sars cell, igm. Coronavirus sars-cov-2 disease
Regeneron announced data on the monoclonal antibody cocktail REGEN-COV showing long-term protection against COVID-19 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip